AWARDBPA CALLOther than small business
BPA call 75F40121F19001DELOITTE CONSULTING LLP
Overview
Award facts
- Net obligations
- $25.18M
- $25,181,678of $25.18M potential value
- Outlays (paid to date)
- $22.82M
- $22.82M paid of $25.18M obligated$22,820,766
- Period of performance
- May 4, 2021 to Jun 30, 2024
- Ended
- Modifications
- 9
- Latest action Jul 28, 2026
- Contract type
- BPA call
- PIID 75F40121F19001
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
WORKFLOW MANAGEMENT (WFM) CENTER OF EXCELLENCE (COE)
Dates and value
- Award date
- Signed on May 4, 2021
- Potential end of performance
- Jun 9, 2026
- Current value
- $25,181,678Base and exercised options
- Potential value (if all options are exercised)
- $25,181,678
- Parent contract vehicle
- 75F40121A00007 (BPA, single award) — 4 orders recorded under it
Obligations by fiscal year of action
- FY2026: -$3,721 (de-obligation)
- FY2023: $9,160,183
- FY2022: $8,324,825
- FY2021: $7,700,391
Total across 4 fiscal years: $25,181,678
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 28, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEICKV2L9GZKJK3
CAGE code1TTG5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP
Business types and certifications
For-profit organizationPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Foods; Human drugs; Devices and radiological health; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Beltsville, Prince Georges County, Maryland 20705-1311
- Congressional district (place of performance)
- MD-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- DG01IT AND TELECOM - NETWORK SUPPORT SERVICES (LABOR) (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
Contract details
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- May 4, 2021Base obligation at award: $6,277,733
- Latest action
- Jul 28, 2026 — CloseoutModification P00009; obligation change -$3,721; administrative: no change in scope or value
- Latest substantive action
- May 30, 2024 — Change orderModification P00008
- Actions by type
- Base award1
- Change order3
- New work added (outside scope)2
- Supplemental agreement (within scope)1
- Option exercised1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$3,721
- Latest action: change in base and all options
- -$3,721
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- Yes
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 10
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2021/2021-0600-000
- 075-2022/2022-0600-000
- 075-2023/2023-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- 25.3: Other goods and services from Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $649,719
- COVID-19 supplemental outlays
- $649,719